Find a clinical trial

Search for clinical trials in your area or further afield. We recommend speaking to your medical team if you find a trial you think you may be eligible for.

Within
miles of
Three female healthcare professionals discuss information at a table

FAIR-O: A study looking at how to deliver better care to older women with ovarian cancer

Around half of women diagnosed with ovarian cancer are over the age of 65. Older women may have different medical and social problems than those seen in younger women. This may result in them being offered less intensive chemotherapy options to treat their ovarian cancer. Research has already shown that in older people who don’t have cancer, und…

A researcher looking into a microscope whilst wearing protective eye wear with her colleague watching

FORECEE: A study looking at female cancer risk prediction

The FORECEE (4C) research project is a new major study investigating the risk of breast, ovarian, womb and cervical cancer. Hormones are known to drive the development of particular diseases in women. Cervical cells are sensitive to the body’s own hormone levels in ways that are similar to the breast and other reproductive organs. This means tha…

Close up of two people with painted nails holding hands

ICON9: A study of olaparib and cediranib in recurrent ovarian cancer

This trial looks to answer the question as to whether two different types of anti-cancer drugs, given as maintenance treatment are: safe effective well-tolerated Maintenance treatment is a type of targeted therapy that is given to try to prevent or delay the cancer's return after it has responded to chemotherapy. The drugs involve…

Equipment used in chemotherapy with a woman looking at her phone during her treatment in the background

LEAP 005: A trial of lenvatinib and pembrolizumab in advanced solid cancers

The purpose of this study is to determine if a combination of two different anti-cancer drugs are safe and effective in treating different types of solid tumours, including ovarian cancer. It's for women with ovarian cancer whose cancer has continued to spread and grow despite standard chemotherapy treatments. The drugs involved in this trial are k…

A nurse talking through a Target Ovarian Cancer leaflet with a woman

MONITOR: A study of maintenance niraparib in clinical practice

The purpose of this study is to help researchers better understand how niraparib is used in the UK and how well it's tolerated by those taking it. Niraparib is a type of drug known as a PARP inhibitor. PARP inhibitors are a relatively new class of drugs known as targeted therapies. In this study the researchers wish to collect real time informat…